// App-Quantinova.ai

118 : Survival of Etanercept (ETN) Responders after Methotrexate (MTX) Failure when ETN is Initiated as Mono or Combination Therapy or ETN Mono Therapy after MTX Withdrawal from ETN/MTX Combination in Long Standing Rheumatoid Arthritis (RA). A Single Center

Researchers

Presenter

  • Sabri Alsaeedi

Principal Investigators

  • Mosaab Makkawy

  • Daming Lin

  • Deborah Weber

  • Ed Keystone

Medical Centers

  • Mount Sinai Hospital, Toronto, ON, Canada

  • St Michael's Hospital, University of Toronto, Toronto, ON, Canada

  • University of Toronto, Prince Mohammed bin Abdulaziz Hospital, Riyadh, Saudi Arabia, Toronto,Canada

  • University of Toronto/ King Saud University, Riyadh, Saudi Arabia, Toronto,Canada

  • University of Toronto/ King Fahd Hospital, Jeddah, Saudi Arabia, Toronto,Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Rheumatoid arthritis

Biomarkers

  • TNF Receptor Superfamily Member 1B

Drug/Treatment

  • Methotrexate

  • Etanercept

  • CHS-0214

Outcome

  • Unknown

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved